1-4 of 4
Julia Karbach
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial

Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, Mohammad-Reza Rafiyan, Salah-Eddin Al-Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4503–4510.
https://doi.org/10.1158/1078-0432.CCR-19-3517
Published: 01 September 2020
View article titled, A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
Open the PDF for A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity

Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, Takamasa Tsuji, Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5449–5459.
https://doi.org/10.1158/1078-0432.CCR-12-1116
Published: 30 September 2012
View article titled, Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity
Open the PDF for Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity in another window
Includes: Supplementary data
Journal Articles

Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients

Julia Karbach, Antje Neumann, Akin Atmaca, Claudia Wahle, Kathrin Brand, Lotta von Boehmer, Alexander Knuth, Armin Bender, Gerd Ritter, Lloyd J. Old, Elke Jäger
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (4): 861–870.
https://doi.org/10.1158/1078-0432.CCR-10-1811
Published: 15 February 2011
View article titled, Efficient <em>In vivo</em> Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients
Open the PDF for Efficient <em>In vivo</em> Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Human CD4+ T Lymphocytes Recognize a Vascular Endothelial Growth Factor Receptor-2–Derived Epitope in Association with HLA-DR

Yuansheng Sun, Mingxia Song, Elke Jäger, Christina Schwer, Stefan Stevanovic, Sven Flindt, Julia Karbach, Xuan D. Nguyen, Dirk Schadendorf, Klaus Cichutek
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (13): 4306–4315.
https://doi.org/10.1158/1078-0432.CCR-07-4849
Published: 01 July 2008
View article titled, Human CD4<sup>+</sup> T Lymphocytes Recognize a Vascular Endothelial Growth Factor Receptor-2–Derived Epitope in Association with HLA-DR
Open the PDF for Human CD4<sup>+</sup> T Lymphocytes Recognize a Vascular Endothelial Growth Factor Receptor-2–Derived Epitope in Association with HLA-DR in another window